ALTEOGEN Valuation
| 196170 Stock | KRW 305,500 8,500 2.86% |
At this time, the firm appears to be overvalued. ALTEOGEN shows a prevailing Real Value of W283185.0 per share. The current price of the firm is W305500.0. Our model approximates the value of ALTEOGEN from analyzing the firm fundamentals such as profit margin of 0.12 %, and Return On Equity of -0.0102 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ALTEOGEN's price fluctuation is very steady at this time. Calculation of the real value of ALTEOGEN is based on 3 months time horizon. Increasing ALTEOGEN's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ALTEOGEN is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ALTEOGEN Stock. However, ALTEOGEN's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 305500.0 | Real 283185.0 | Hype 305500.0 | Naive 236745.0 |
The real value of ALTEOGEN Stock, also known as its intrinsic value, is the underlying worth of ALTEOGEN Company, which is reflected in its stock price. It is based on ALTEOGEN's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ALTEOGEN's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ALTEOGEN helps investors to forecast how ALTEOGEN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ALTEOGEN more accurately as focusing exclusively on ALTEOGEN's fundamentals will not take into account other important factors: ALTEOGEN Total Value Analysis
ALTEOGEN is presently forecasted to have takeover price of 3.27 T with market capitalization of 549.88 B, debt of 1.07 B, and cash on hands of 10.54 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ALTEOGEN fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.27 T | 549.88 B | 1.07 B | 10.54 B |
ALTEOGEN Investor Information
About 31.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. ALTEOGEN had 6:5 split on the 25th of October 2022. Based on the analysis of ALTEOGEN's profitability, liquidity, and operating efficiency, ALTEOGEN is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.ALTEOGEN Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ALTEOGEN has an asset utilization ratio of 15.8 percent. This suggests that the Company is making W0.16 for each dollar of assets. An increasing asset utilization means that ALTEOGEN is more efficient with each dollar of assets it utilizes for everyday operations.ALTEOGEN Ownership Allocation
The market capitalization of ALTEOGEN is W549.88 Billion. ALTEOGEN retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.ALTEOGEN Profitability Analysis
The company reported the revenue of 41.12 B. Net Loss for the year was (3.88 B) with profit before overhead, payroll, taxes, and interest of 8.08 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ALTEOGEN's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ALTEOGEN and how it compares across the competition.
About ALTEOGEN Valuation
The stock valuation mechanism determines ALTEOGEN's current worth on a weekly basis. Our valuation model uses a comparative analysis of ALTEOGEN. We calculate exposure to ALTEOGEN's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ALTEOGEN's related companies.8 Steps to conduct ALTEOGEN's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ALTEOGEN's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ALTEOGEN's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ALTEOGEN's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ALTEOGEN's revenue streams: Identify ALTEOGEN's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ALTEOGEN's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ALTEOGEN's growth potential: Evaluate ALTEOGEN's management, business model, and growth potential.
- Determine ALTEOGEN's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ALTEOGEN's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ALTEOGEN Stock analysis
When running ALTEOGEN's price analysis, check to measure ALTEOGEN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALTEOGEN is operating at the current time. Most of ALTEOGEN's value examination focuses on studying past and present price action to predict the probability of ALTEOGEN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALTEOGEN's price. Additionally, you may evaluate how the addition of ALTEOGEN to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |